NUVO
Holdco Nuvo Group D.G Ltd. Ordinary Shares
NASDAQ · Healthcare · Medical - Devices · IL
$0.17
+0.00%Income statement
| Metric | TTM | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 49.00 | 176.0K | — | — | — |
| Cost of Revenue | 100.00 | 191.0K | — | — | — |
| Gross Profit | (51.00) | (15.0K) | — | — | — |
| Operating Expenses | |||||
| R&D Expense | 4.6K | 8.3M | 9.9M | 10.5M | 6.9K |
| SG&A Expense | 8.6M | 8.3M | 1.7M | 212.3K | 4.4K |
| General & Admin Expense | 2.2K | 7.7M | 10.4M | 16.8M | 2.9K |
| Selling & Marketing Expense | 1.8K | 583.0K | 509.0K | 282.0K | 1.5K |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 8.6M | 16.6M | 1.7M | 212.3K | 11.2K |
| Cost and Expenses | 8.6M | 16.8M | 1.7M | 212.3K | 11.2K |
| Operating Income (EBIT) | (8.6M) | (16.6M) | (1.7M) | (212.3K) | (11.3K) |
| Non-Operating | |||||
| Interest Income | 4.2M | — | — | — | — |
| Interest Expense | — | 44.0K | 69.0K | 565.0K | — |
| Net Interest Income | 4.2M | (44.0K) | (69.0K) | (565.0K) | — |
| Other Non-Op Income/Expense | 5.2M | (18.1M) | 23.1M | 27.4M | 30.00 |
| Non-Operating Income (excl Interest) | — | 18.0M | (23.1M) | (565.0K) | — |
| EBT (Pre-Tax Income) | (3.5M) | (34.7M) | 2.3M | (212.2K) | (11.2K) |
| Income Tax Expense | — | (1.0M) | — | — | — |
| Bottom Line | |||||
| Net Income | (3.5M) | (33.7M) | 2.3M | (212.2K) | (11.2K) |
| Earnings from Cont. Ops | (3.5M) | (33.7M) | 2.3M | (212.2K) | (11.2K) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (3.5M) | (33.7M) | 2.3M | (212.2K) | (11.2K) |
| Per Share | |||||
| Basic EPS | ($0.36) | ($1.64) | $0.06 | ($0.01) | ($0.68) |
| Diluted EPS | ($0.36) | ($1.64) | $0.06 | ($0.01) | ($0.68) |
| Revenue Per Share | $0.00 | $0.01 | $0.00 | $0.00 | $0.00 |
| Shares | |||||
| Basic Shares Outstanding | 12.5M | 20.6M | 34.8M | 34.8M | 16566 |
| Diluted Shares Outstanding | 12.5M | 20.6M | 34.8M | 34.8M | 16566 |
| Profitability Metrics | |||||
| EBITDA | (5.7M) | (34.4M) | (1.7M) | (27.4M) | (11.1K) |
| D&A | 121.00 | 206.0K | 495.0K | 214.0K | 203.00 |
| EBIT | — | (34.6M) | 2.3M | (27.0M) | (11.3K) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Dec 1, 2023